Skip to content

Clinical trials

Phase 2 Psoriasis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psoriasis Phase: Phase 2 Country / region: Canada Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20052
20063
20071
20084
20091
20101
20113
20121
20133
20143
20153
20165
20173
20183
20198
20202
20213
20222
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44
Terminated9
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim7
Pfizer7
UCB Biopharma SRL4
Amgen3
Bristol-Myers Squibb3
Akros Pharma Inc.2
Arcutis Biotherapeutics, Inc.2
Aristea Therapeutics, Inc.2
Eli Lilly and Company2
Galderma R&D2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psoriasis56
Skin Diseases7
Lymphoma, Follicular3
Pruritus3
Arthritis, Psoriatic2
Plaque, Amyloid2
Bronchiolitis Obliterans Syndrome1
Diabetes Mellitus, Type 21
Eczema1
Glucose Intolerance1

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.